Table 1.
Early-Onset MI Patients N = 2081 | Controls N = 3761 | |
---|---|---|
Race, N (%) | ||
White | 1537 (74%) | 1544 (41%) |
Black | 336 (16%) | 962 (26%) |
Hispanic | 168 ( 8%) | 751 (20%) |
Asian | 40 ( 1.9%) | 504 (13%) |
Male sex, N (%) | 709 (34%) | 1731 (46%) |
Age, years; Mean (SD) | 47.6 (5.9) | 60.3 (9.7) |
Hypertension, N (%) | 1345 (65%) | 1467 (39%) |
Diabetes, N (%) | 735 (36%) | 358 ( 9.5%) |
Current Smoking, N (%) | 1055 (51%) | 437 (12%) |
Statin Use, N (%) | 575 (28%) | 527 (14%) |
Lipid Levels, mg/dl | ||
LDL Cholesterol; Mean (SD)* | 125 (49) | 123 (34) |
HDL Cholesterol; Mean (SD) | 40 (14) | 53 (15) |
Triglycerides; Median (Q1—Q3) | 136 [93, 210] | 110 [77, 159] |
MI – myocardial infarction; N – number; SD – standard deviation; LDL – low density lipoprotein; HDL – high density lipoprotein; Q1 – quartile 1; Q3 – quartile 3
In order to estimate untreated values for low-density lipoprotein cholesterole, measured values for those reporting use of statin medications were divided by 0.7.